American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

V40N5: Breast Diseases

Recommended Reading

Bonnefoi H, Litiere S, Piccart M, et al. Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial. Ann Oncol. 2014 Jun;25(6):1128-36.

This study presents data supporting the positive effect of complete response to neoadjuvant chemotherapy on breast cancer outcomes.

Eroles P, Bosch A, Perez-Fidalgo JA, et al. Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. Cancer Treat Rev. 2012;38(6):698-707.

This article presents a valuable review of current knowledge relevant to molecular subtypes in breast cancers.

Houssami N, Macaskill P, Marinovich ML, et al. The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2014;21(3):717-730.

The new definition of “adequate” surgical margins for excisional biopsy on patients who are candidates for breast conservation is confirmed with data from this metaanalysis.

King TA, Gurevich I, Sakr R, et al. Occult malignancy in patients undergoing contralateral prophylactic mastectomy. Ann Surg. 2011;254(1):2-7.  

Data from this study confirms the low risk of breast malignancy in contralateral breasts removed prophylactically after therapeutic mastectomy on the opposite side.

Morrow M. Refining the use of endocrine therapy for ductal carcinoma in situ. J Clin Oncol. 2012;30(12):1249-1251.

This article provides valuable information on the current use of endocrine therapy for DCIS.

Morrow M. Personalizing extent of breast cancer surgery according to molecular subtypes. Breast. 2013;22 Suppl 2:S106-109.

This article reviews data supporting the personalization of breast cancer treatment strategies based on molecular markers.

Neal L, Sandhu NP, Hieken TJ, et al. Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. Mayo Clin Proc. 2014;89(4):536-547.

This review article provides valuable perspective on the management of a variety of benign lesions that may be associated with increased cancer risk.

Trebska-McGowan K, Terracina KP, Takabe K. Update on the surgical management of Paget's disease. Gland Surg. 2013;2(3). Free full text

This is a useful review of the diagnosis and management of Paget’s disease of the breast.